1. Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study. Issue 5 (20th September 2022) Authors: Qu, Wei-Feng; Ding, Zhen-Bin; Qu, Xu-Dong; Tang, Zheng; Zhu, Gui-Qi; Fu, Xiu-Tao; Zhang, Zi-Han; Zhang, Xin; Huang, Ao; Tang, Min; Tian, Meng-Xin; Jiang, Xi-Fei; Huang, Run; Tao, Chen-Yang; Fang, Yuan; Gao, Jun; Wu, Xiao-Ling; Zhou, Jian; Fan, Jia; Liu, Wei-Ren Journal: BJS open Issue: Volume 6:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗